BOULDER, CO – OPX Biotechnologies Inc. has raised $36.5 million in the first closing of its C-Round private equity financing. The investment will enable OPXBIO to accelerate development and commercialization of an industrial-scale process for producing its first renewable chemical, BioAcrylic. OPXBIO has established a joint development agreement with The Dow Chemical Co. to collaborate on the large-scale demonstration of the process for BioAcrylic production and anticipates full commercialization within three to five years.